|
2025 Other Outputs Oxytocin receptor tracerPerisic, Monika, Kalaba, Predrag, Gruber, Christian W., Keimpema, Erik and Muttenthaler, Markus (2025). Oxytocin receptor tracer. EP25181359. |
|
2023 Other Outputs Highly stable oxytocin derivativesKremsmayr, Thomas and Muttenthaler, Markus (2023). Highly stable oxytocin derivatives. WO2023118303A1. |
|
2022 Other Outputs De novo design of peptide-small molecule ligands of the kappa-opioid receptorsMuratspahic, E., Muttenthaler, M., Jadhav, K. B., Baker, D., Che, T., Spetea, M., Craik, D. and Gruber, C. W. (2022). De novo design of peptide-small molecule ligands of the kappa-opioid receptors. EP22193238. |
|
2019 Other Outputs Novel oxytocin analoguesMuttenthaler, M., Hering, A., Pascali, G. and Guastella, A. (2019). Novel oxytocin analogues. 1002581997. |
|
2019 Other Outputs Use of single dendritic wedge cell penetrating peptides to facilitate cellular delivery of nanoparticles and nanoparticles carrying cargosMuttenthaler, M., Breger, J.C., Delehanty, J.B., Ricks-Laskoski, H., Dawson, P.E. and Medintz, I.L. (2019). Use of single dendritic wedge cell penetrating peptides to facilitate cellular delivery of nanoparticles and nanoparticles carrying cargos. US10183080B2. |
|
2009 Other Outputs Peptide engineering - controlling the folding of disulfide-rich peptidesMuttenthaler, Markus (2009). Peptide engineering - controlling the folding of disulfide-rich peptides. PhD Thesis, Institute for Molecular Bioscience, The University of Queensland. |
